CellaVision AB
- BID
13.04
- ASK
13.26
- 383 Units377 Units
- 07/21, 16:34:07 PM
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
17.54%
Market Cap
-
P/E Ratio
24.49
Dividend Yield
1.75 %
Earnings per Share
0.58 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 90.93 Bil. | 31.27 Bil. | 22.35 | -4.61 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 13.04 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 04:34:07 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 13.34 | 12.86 |
| PREV. DAY'S PRICE | 13.26 | (07/20) |
| CHANGE DAY BEFORE | -0.22 | -1.66 % |
| 52 WEEK HIGH / LOW | 17.2 (10/24) | 10.64 (05/12) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.48 | 0.52 | 0.58 | 0.54 | 0.66 |
DIVIDENDS PER SHARE | 0.20 | 0.22 | 0.25 | 0.25 | 0.27 |
DIVIDEND YIELD IN % | 1.06 % | 1.15 % | 1.75 % | - | - |
DIVIDEND GROWTH IN % | -7.59 % | 11.44 % | 13.89 % | - | - |
PRICE - EARNINGS RATIO | 38.81 | 36.87 | 24.49 | 24.86 | 20.16 |
PRICE - BOOK RATIO | 7.06 | 6.36 | 4.22 | - | - |
PRICE - SALES RATIO | 7.47 | 7.17 | 4.94 | - | - |
PRICE - CASH FLOW RATIO | 25.74 | 26.14 | 18.70 | - | - |
Master Data
| WKN | A0NEVD |
| ISIN | SE0000683484 |
| SYMBOL | C26 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | CELLAVISION AB SK -,15 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 7.98 % | 7.80 % | -9.18 % | -8.80 % | -17.54 % | -19.83 % | -64.85 % | -7.40 % |
| HIGH | 13.66 | 13.66 | 14.90 | 15.28 | 17.20 | 25.65 | 48.74 | 15.28 |
| LOW | 11.64 | 11.64 | 10.64 | 10.64 | 10.64 | 10.42 | 10.42 | 10.64 |
Dividende
pro Aktie
Company profile
CellaVision AB engages in the provision of digital microscopy solutions for hematology laboratories. The firm's products include Analyzers, Instruments, DIFF-Line™ by CellaVision, Reagents, and Software and applications. It operates through the following geographical segments: Americas, APAC, and EMEA. The company was founded by Lars Christer Fedrik Fåhraeus on November 16, 1994 and is headquartered in Lund, Sweden.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.